Cargando…
First Episode of Psychosis in the Context of Varenicline Treatment for Smoking Cessation
Smoking is one of the leading causes of preventable death worldwide. Several pharmacological therapies have been established over the years to aid in smoking cessation, including Varenicline, a partial nicotine agonist. Neuropsychiatric adverse events have been reported in patients treated with Vare...
Autores principales: | Zoghbi, Yuri, Barazi, Raja, Abdelkader, Menatalla H, Eltorki, Yassin H, Ghuloum, Suhaila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125011/ https://www.ncbi.nlm.nih.gov/pubmed/37102012 http://dx.doi.org/10.7759/cureus.36677 |
Ejemplares similares
-
Efficacy and Safety of Varenicline for Smoking Cessation in Schizophrenia: A Meta-Analysis
por: Ahmed, Saeed, et al.
Publicado: (2018) -
Smoking cessation therapy with varenicline
por: Mohanasundaram, Uma M, et al.
Publicado: (2008) -
Knowledge, attitude, and practice related to COVID-19: A comparison between patients with mental illness and the general population in Qatar
por: Ghuloum, Suhaila, et al.
Publicado: (2022) -
Smoking cessation in Asians: focus on varenicline
por: Xiao, Dan, et al.
Publicado: (2015) -
Smoking cessation: an economic analysis and review of varenicline
por: Faulkner, Michele A
Publicado: (2009)